Understanding of and clinical approach to cardiometabolic transition at the menopause

References

• Baber RJ, Panay N, Fenton A. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
   PubMed Web of Science ®Google Scholar
• Lambrinoudaki I, Armeni E, Goulis D, et al. Menopause, wellbeing and health: a care pathway from the European Menopause and Andropause Society. Maturitas. 2022;163:1–14.
   PubMed Web of Science ®Google Scholar
• Rees M, Abernethy K, Bachmann G, et al. The essential menopause curriculum for healthcare professionals: a European Menopause and Andropause Society (EMAS) position statement. Maturitas. 2022;158:70–77.
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168.
   PubMed Web of Science ®Google Scholar
• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446.
   PubMed Web of Science ®Google Scholar
• Davis SR, Lambrinoudaki I, Lumsden M, et al. Menopause. Nat Rev Dis Primers. 2015;1:15004.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215.
   PubMed Web of Science ®Google Scholar
• Lopez AD, Adair T. Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics. Int J Epidemiol. 2019;48(6):1815–1823.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Smyth A, Rangarajan S, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, Middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):e748–e760.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Chedraui P, Lambrinoudaki I, et al. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442–456.
   PubMed Web of Science ®Google Scholar
• Lamelas PM, Yusuf S, Schwalm JD. Effective approaches to address the global cardiovascular disease burden. Curr Opin Cardiol. 2017;32(5):557–566.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Wildman RP, Matthews K, et al. Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. Menopause. 2013;20(1):8–14.
   PubMed Web of Science ®Google Scholar
• Stamatelopoulos KS, Armeni E, Georgiopoulos G, et al. Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men. Atherosclerosis. 2012;221(2):508–513.
   PubMed Web of Science ®Google Scholar
• Moreau KL, Hildreth KL, Meditz AL, et al. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab. 2012;97(12):4692–4700.
   PubMed Web of Science ®Google Scholar
• Samargandy S, Matthews KA, Brooks MM, et al. Arterial stiffness accelerates within 1 year of the final menstrual period: the SWAN heart study. Arterioscler Thromb Vasc Biol. 2020;40(4):1001–1008.
   PubMed Web of Science ®Google Scholar
• Davis SR. Testosterone for women: certainties and uncertainties. Climacteric. 2023;26(1):21–24.
   PubMed Web of Science ®Google Scholar
• Markopoulos MC, Kassi E, Alexandraki KI, et al. Hyperandrogenism after menopause. Eur J Endocrinol. 2015;172(2):R79–91.
   PubMed Web of Science ®Google Scholar
• Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015;72:1–75.
   PubMed Web of Science ®Google Scholar
• Mumusoglu S, Yildiz BO. Metabolic syndrome during menopause. Curr Vasc Pharmacol. 2019;17(6):595–603.
   PubMed Web of Science ®Google Scholar
• Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021;35(5–6):307–328.
   PubMed Web of Science ®Google Scholar
• Kapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin Proc. 2017;92(10):1552–1558.
   PubMed Web of Science ®Google Scholar
• Konttinen H, van Strien T, Männistö S, et al. Depression, emotional eating and long-term weight changes: a population-based prospective study. Int J Behav Nutr Phys Act. 2019;16(1):28.
   PubMedGoogle Scholar
• Wu D, Gao X, Shi Y, et al. Association between handgrip strength and the systemic Immune-Inflammation index: a nationwide study, NHANES 2011–2014. Int J Environ Res Public Health. 2022;19(20):13616.
   PubMed Web of Science ®Google Scholar
• Lambrinoudaki I, Paschou SA, Armeni E, et al. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol. 2022;18(10):608–622.
   PubMed Web of Science ®Google Scholar
• Pafili K, Paschou SA, Armeni E, et al. Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones. J Endocrinol Invest. 2022;45(9):1609–1623.
   PubMed Web of Science ®Google Scholar
• de Kat AC, Dam V, Onland-Moret NC, et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017;15(1):2.
   PubMedGoogle Scholar
• Anagnostis P, Stevenson JC, Crook D, et al. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas. 2015;81(1):62–68.
   PubMed Web of Science ®Google Scholar
• Ambikairajah A, Walsh E, Cherbuin N. Lipid profile differences during menopause: a review with meta-analysis. Menopause. 2019;26(11):1327–1333.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Hutchins PM, Matthews KA, et al. Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause. J Clin Endocrinol Metab. 2016;101(9):3419–3428.
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506–e532.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Lambrinoudaki I, Stevenson JC, et al. Menopause-associated risk of cardiovascular disease. Endocr Connect. 2022;11(4):e210537.
   PubMed Web of Science ®Google Scholar
• Wenger NK, Arnold A, Bairey Merz CN, et al. Hypertension across a Woman’s Life Cycle. J Am Coll Cardiol. 2018;71(16):1797–1813.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou X, Guo X, et al. Prevalence and risk factors of hypertension among pre- and post-menopausal women: a cross-sectional study in a rural area of northeast China. Maturitas. 2015;80(3):282–287.
   PubMed Web of Science ®Google Scholar
• Ying W, Post WS, Michos ED, et al. Associations between menopause, cardiac remodeling, and diastolic function: the CARDIA study. Menopause. 2021;28(10):1166–1175.
   PubMed Web of Science ®Google Scholar
• Zhu D, Chung HF, Dobson AJ, et al. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Am J Obstet Gynecol. 2020;223(6):898.e1–898.e16.
   PubMed Web of Science ®Google Scholar
• Gray KE, Katon JG, LeBlanc ES, et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Menopause. 2018;25(5):520–530.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc. 2021;10(3):e017416.
   PubMed Web of Science ®Google Scholar
• Biglia N, Cagnacci A, Gambacciani M, et al. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017;20(4):306–312.
   PubMed Web of Science ®Google Scholar
• Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al. Vasomotor symptoms and insulin resistance in the study of women’s health across the nation. J Clin Endocrinol Metab. 2012;97(10):3487–3494.
   PubMed Web of Science ®Google Scholar
• Ryu KJ, Park H, Park JS, et al. Vasomotor symptoms: more than temporary menopausal symptoms. J Menopausal Med. 2020;26(3):147–153.
   PubMedGoogle Scholar
• Nasr A, Matthews KA, Brooks MM, et al. Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: does level of endogenous estradiol matter? The SWAN HDL ancillary study. J Clin Lipidol. 2020;14(5):685–694.e2.
   PubMed Web of Science ®Google Scholar
• Herber-Gast G, Brown WJ, Mishra GD. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study. BJOG. 2015;122(11):1560–1567.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Colpani V, et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2016;11(6):e0157417.
   PubMed Web of Science ®Google Scholar
• Nudy M, Aragaki AK, Jiang X, et al. The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women’s Health Initiative Observational Cohort. Menopause. 2022;29(12):1365–1374.
   PubMedGoogle Scholar
• Maas A, Rosano G, Cifkova R, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021;42(10):967–984.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Kunutsor S, et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016;1(7):767–776.
   PubMed Web of Science ®Google Scholar
• Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41(2):255–323.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646.
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337.
   PubMed Web of Science ®Google Scholar
• Zhu D, Chung HF, Dobson AJ, et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum Reprod. 2020;35(8):1933–1943.
   PubMed Web of Science ®Google Scholar
• Price MA, Alvarado BE, Rosendaal NTA, et al. Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging. Menopause. 2021;28(5):484–490.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(25):e1082–e1143.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Bitzer J, Cano A, et al. Menopause symptom management in women with dyslipidemias: an EMAS clinical guide. Maturitas. 2020;135:82–88.
   PubMed Web of Science ®Google Scholar
• Slopien R, Wender-Ozegowska E, Rogowicz-Frontczak A, et al. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018;117:6–10.
   PubMed Web of Science ®Google Scholar
• Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30(3):160–164.
   PubMed Web of Science ®Google Scholar
• Chakraborty DS, Lahiry S, Choudhury S. Hypertension clinical practice guidelines (ISH, 2020): what is new? Med Princ Pract. 2021;30(6):579–584.
   PubMed Web of Science ®Google Scholar
• Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34.
   PubMed Web of Science ®Google Scholar
• Chiavaroli L, Viguiliouk E, Nishi SK, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338.
   PubMed Web of Science ®Google Scholar
• Roberts SB, Silver RE, Das SK, et al. Healthy aging-nutrition matters: start early and screen often. Adv Nutr. 2021;12(4):1438–1448.
   PubMed Web of Science ®Google Scholar
• Hirahatake KM, Jiang L, Wong ND, et al. Diet quality and cardiovascular disease risk in postmenopausal women with type 2 diabetes mellitus: the women’s health initiative. J Am Heart Assoc. 2019;8(19):e013249.
   PubMed Web of Science ®Google Scholar
• Stamatelopoulos K, Tsoltos N, Armeni E, et al. Physical activity is associated with lower arterial stiffness in normal-weight postmenopausal women. J Clin Hypertens (Greenwich). 2020;22(9):1682–1690.
   PubMed Web of Science ®Google Scholar
• Chrysant SG. The cardiometabolic benefits of exercise in postmenopausal women. J Clin Hypertens (Greenwich). 2020;22(9):1691–1693.
   PubMed Web of Science ®Google Scholar
• Manojlović M, Protić-Gava B, Maksimović N, et al. Effects of combined resistance and aerobic training on arterial stiffness in postmenopausal women: a systematic review. Int J Environ Res Public Health. 2021;18(18):9450.
   PubMed Web of Science ®Google Scholar
• Clark A, Mach N. The crosstalk between the gut microbiota and mitochondria during exercise. Front Physiol. 2017;8:319.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Petersen KS, Després JP, et al. Strategies for promotion of a healthy lifestyle in clinical settings: pillars of ideal cardiovascular health: a science advisory from the American Heart Association. Circulation. 2021;144(24):e495–e514.
   PubMed Web of Science ®Google Scholar
• Karim R, Xu W, Kono N, et al. Effect of menopausal hormone therapy on arterial wall echomorphology: results from the early versus late intervention trial with estradiol (ELITE). Maturitas. 2022;162:15–22.
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221–1231.
   PubMed Web of Science ®Google Scholar
• Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353–1368.
   PubMed Web of Science ®Google Scholar
• Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA. 2017;318(10):927–938.
   PubMed Web of Science ®Google Scholar
• Manson JE, Aragaki AK, Bassuk SS, et al. Menopausal estrogen-alone therapy and health outcomes in women with and without bilateral oophorectomy: a randomized trial. Ann Intern Med. 2019;171(6):406–414.
   PubMed Web of Science ®Google Scholar
• Nudy M, Chinchilli VM, Foy AJ. A systematic review and meta-regression analysis to examine the ‘timing hypothesis’ of hormone replacement therapy on mortality, coronary heart disease, and stroke. Int J Cardiol Heart Vasc. 2019;22:123–131.
   PubMed Web of Science ®Google Scholar